Literature DB >> 21371579

EASL Clinical Practice Guidelines: management of hepatitis C virus infection.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21371579     DOI： 10.1016/j.jhep.2011.02.023

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  349 in total

1.  Finasteride and methadone use and risk of advanced hepatitis C related liver disease.

Authors:  Donna L White; Ali Hashmi; David J Ramsey; Jill Kuzniarek; Shahriar Tavakoli-Tabasi; Hashem B El-Serag
Journal:  Dig Dis Sci       Date:  2012-06-05       Impact factor: 3.199

2.  IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection.

Authors:  Vito Di Marco; Fabrizio Bronte; Vincenza Calvaruso; Marcello Capra; Zelia Borsellino; Aurelio Maggio; Maria Concetta Renda; Lorella Pitrolo; Maria Carmela Lo Pinto; Michele Rizzo; Flavia Fiorenza; Calogera Gerardi; Stefania Grimaudo; Antonietta Di Cristina; Massimo Levrero; Antonio Craxì
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

3.  Behavior of soluble HLA-A, -B, -C and HLA-G molecules in patients with chronic hepatitis C virus infection undergoing pegylated interferon-α and ribavirin treatment: potential role as markers of response to antiviral therapy.

Authors:  Giuseppe Murdaca; Paola Contini; Paola Cagnati; Simona Marenco; Giulia Pieri; Francesca Lantieri; Antonino Picciotto; Francesco Puppo
Journal:  Clin Exp Med       Date:  2015-11-14       Impact factor: 3.984

4.  Anti-Nuclear Cytoplasmic Antibody-Associated Vasculitis: A Probable Adverse Effect of Sofosbuvir Treatment in Chronic Hepatitis C Patients.

Authors:  Youssef K Ahmad; Salwa Tawfeek; Mohamed Sharaf-Eldin; Hassan E Elbatea; Abdelrahman Kobtan; Ferial El-Kalla; Rehab Badawi; Sherief Abd-Elsalam
Journal:  Hosp Pharm       Date:  2017-04

5.  Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program.

Authors:  Melissa R Stein; Irene J Soloway; Karen S Jefferson; Robert J Roose; Julia H Arnsten; Alain H Litwin
Journal:  J Subst Abuse Treat       Date:  2012-10-02

Review 6.  Psychosocial assessment and monitoring in the new era of non-interferon-alpha hepatitis C virus treatments.

Authors:  Paul J Rowan; Nizar Bhulani
Journal:  World J Hepatol       Date:  2015-09-08

7.  Effect of alcohol consumption on liver stiffness measured by transient elastography.

Authors:  Edouard Bardou-Jacquet; Ludivine Legros; Draman Soro; Marianne Latournerie; Anne Guillygomarc'h; Caroline Le Lan; Pierre Brissot; Dominique Guyader; Romain Moirand
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

8.  Role of genetic polymorphisms in hepatitis C virus chronic infection.

Authors:  Nicola Coppola; Mariantonietta Pisaturo; Caterina Sagnelli; Lorenzo Onorato; Evangelista Sagnelli
Journal:  World J Clin Cases       Date:  2015-09-16       Impact factor: 1.337

9.  Acute hepatitis C virus infection in a nurse trainee following a needlestick injury.

Authors:  Renzo Scaggiante; Liliana Chemello; Roberto Rinaldi; Giovanni Battista Bartolucci; Andrea Trevisan
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

10.  The Cobas AmpliPrep/Cobas TaqMan HCV test, version 2.0, real-time PCR assay accurately quantifies hepatitis C virus genotype 4 RNA.

Authors:  Stéphane Chevaliez; Magali Bouvier-Alias; Christophe Rodriguez; Alexandre Soulier; Jean-Dominique Poveda; Jean-Michel Pawlotsky
Journal:  J Clin Microbiol       Date:  2013-01-16       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.